Six Dallas-area pharmacy owners and marketers were charged in connection with a kickback scheme involving compound drug claims to Tricare and the U.S. Department of Labor.
In a May 13 news release, the Department of Justice alleged that $14 million in illegal kickbacks and bribes were paid after physicians prescribed compounded drugs covered by federal insurance.
The pharmacy owners oversaw two pharmacies, Rxpress and Xpress, that shared the same staff and operated out of the same building. The indictment alleges that both companies used the same marketers but paid them differently, depending on if they received a commission on a federal or private prescription, to disguise their illegal activities.
This superseding indictment comes after an initial indictment filed in the Northern District of Texas in December 2018.
The superseding indictment includes the following charges:
- conspiracy to defraud the United States and pay and receive kickbacks
- paying and/or receiving kickbacks
- conspiracy to commit money laundering by concealing proceeds of the unlawful kickbacks
- conspiracy to commit money laundering by engaging in monetary transactions in criminally derived property
- engaging in monetary transactions in criminally derived property
More articles on pharmacy:
Sanofi CEO blasted for saying US should get coronavirus vaccine first
Providence chief pharmacy officer on how his team has succeeded through the COVID-19 pandemic
Moderna releases positive data on early COVID-19 vaccine trial
COVID-19 Coverage
E-Newsletters
Conferences
Virtual Conferences
Webinars
Whitepapers
Podcasts
Print Issue
Multimedia
Lists
About Us
Physicians
Leadership
Strategy
Executive Moves
Transaction & Valuation
HR
Patient Flow
Capital
Telehealth
Cardiology
Oncology
Supply Chain
Orthopedics
Patient Experience
Pharmacy
Care Coordination
Legal & Regulatory
Compensation
Payer
Opioids
Rankings & Ratings
Post-Acute
Workforce
Moderna releases positive data on early COVID-19 vaccine trial